GE HealthCare and Indonesia’s Ministry of Health to expand access to quality care through the provision of 300+ advanced CT scanners

GE HealthCare (Nasdaq: GEHC) today announced it will supply more than 300 CT (computed tomography) scanners under Indonesia’s Strengthening Indonesia’s Health Referral Network (SIHREN) program to deliver equitable, high-quality care to more than 280 million Indonesians. As part of a competitively awarded, multi-year contract, GE HealthCare will supply the advanced CT scanners to public hospitals across all 38 provinces, including urban and remote areas. The CT scanner procurement under SIHREN was conducted through a fully competitive international tender process governed by the World Bank’s procurement regulations.

SIHREN is the largest healthcare infrastructure investment in Indonesia’s history and among the largest multilateral health projects globally. SIHREN aims to modernize the national referral system and expand access to diagnostics and treatment across the archipelago, with a focus on non-communicable diseases (NCD) management, maternal health, and pandemic resilience.

By modernizing the referral network and expanding access to advanced diagnostics across all provinces, the collaboration is bringing equitable, high-quality care closer to every community—urban and remote alike. Access to life-saving CT technology will enable early detection and timely treatment of critical conditions such as cancer, stroke, and heart disease, helping save lives and improve health outcomes for Indonesians nationwide.

“We are proud to support the Indonesian Ministry of Health’s vision,” said Elie Chaillot, President & CEO, International at GE HealthCare. “Our ongoing investments in local manufacturing, capacity building and training reflect our commitment to contribute to Indonesia’s healthcare resilience and drive local economic growth. Equally important, this initiative helps ensure that advanced diagnostic technologies reach rural and remote communities, promoting healthcare equity and bringing life-saving care closer to every Indonesian.”

CT scanners have become essential in modern healthcare. Using X-ray beams and advanced computer processing, CT scanners provide fast, detailed 2D and 3D images of the internal organs, bones, blood vessels, and soft tissues, helping doctors diagnose injuries and illnesses quickly. CT technology enables early detection of conditions, determines the size and spread of tumors or infections, monitors treatment effectiveness (such as chemotherapy or radiotherapy), and guides procedures like biopsies in deep organs.

To deepen its local footprint, GE HealthCare recently inaugurated a production facility in Bogor, in collaboration with PT Kalbe Farma’s subsidiary, Forsta. This local manufacturing facility is aimed at strengthening Indonesia’s supply chain resilience, supporting technology transfer and helping develop a skilled local healthcare and technical workforce.

For over seven decades, GE HealthCare has collaborated with Indonesia’s public and private healthcare sectors. In early 2025, GE HealthCare was awarded a tender to supply 10 1.5T MR systems to public hospitals. High resolution MR imaging enables early, accurate diagnosis and ongoing monitoring of conditions like cancer, stroke and heart disease, and is critical for effective non-communicable disease management.

In 2024, GE HealthCare established the Regional Innovation & Training Experience (RITE) Hub in Jakarta. The center provides Indonesian healthcare professionals with hands-on training on advanced imaging technologies, including MR and CT systems, and collaborates with leading educational institutions to deliver programs covering device operation and clinical pathways. By equipping clinicians with practical skills and knowledge, the center strengthens local expertise and ensures medical technologies are used to their maximum potential across Indonesia.

About GE HealthCare Technologies Inc.

GE HealthCare is a trusted partner and leading global healthcare solutions provider, innovating medical technology, pharmaceutical diagnostics, and integrated, cloud-first AI-enabled solutions, services and data analytics. We aim to make hospitals and health systems more efficient, clinicians more effective, therapies more precise, and patients healthier and happier. Serving patients and providers for more than 125 years, GE HealthCare is advancing personalized, connected and compassionate care, while simplifying the patient’s journey across care pathways. Together, our Imaging, Advanced Visualization Solutions, Patient Care Solutions and Pharmaceutical Diagnostics businesses help improve patient care from screening and diagnosis to therapy and monitoring. We are a $19.7 billion business with approximately 53,000 colleagues working to create a world where healthcare has no limits.

GE HealthCare is proud to be among 2025 Fortune World’s Most Admired Companies™.

Follow us on LinkedIn, X, Facebook, Instagram, and Insights for the latest news, or visit our website https://www.gehealthcare.com for more information.

View source version on businesswire.com: https://www.businesswire.com/news/home/20251216956209/en/